Additionally, developing specific c-Fos inhibitors or ER agonists and validating their efficacy in animal models and clinical samples could provide new theoretical foundations and intervention targets for the precision treatment of PCOS. The gene discussed is ESR1; the disease is polycystic ovary syndrome.